215 related articles for article (PubMed ID: 22115957)
1. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin.
Fouad YM; Khalaf H; Ibraheem H; Rady H; Helmy AK
Int J Infect Dis; 2012 Jan; 16(1):e67-71. PubMed ID: 22115957
[TBL] [Abstract][Full Text] [Related]
2. Is combination therapy interferon and ribavirin in patients with chronic hepatitis C infection toxic for eyes?
Mousa N; Besheer T; Gad Y; Elbendary A; Mokbel T; Abdel-Aziz A
J Ocul Pharmacol Ther; 2013 Apr; 29(3):345-8. PubMed ID: 23113644
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C.
Okuse C; Yotsuyanagi H; Nagase Y; Kobayashi Y; Yasuda K; Koike K; Iino S; Suzuki M; Itoh F
World J Gastroenterol; 2006 Jun; 12(23):3756-9. PubMed ID: 16773695
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection.
Panetta JD; Gilani N
Aliment Pharmacol Ther; 2009 Sep; 30(6):597-602. PubMed ID: 19549263
[TBL] [Abstract][Full Text] [Related]
5. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening.
Vujosevic S; Tempesta D; Noventa F; Midena E; Sebastiani G
Hepatology; 2012 Aug; 56(2):455-63. PubMed ID: 22331668
[TBL] [Abstract][Full Text] [Related]
6. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Moisseiev E; Goldenberg D; Kurtz S
Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
[TBL] [Abstract][Full Text] [Related]
7. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Burgueño-Montañés C; Pérez-Álvarez R
Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
9. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection.
Sulkowski MS; Wasserman R; Brooks L; Ball L; Gish R
J Viral Hepat; 2004 May; 11(3):243-50. PubMed ID: 15117326
[TBL] [Abstract][Full Text] [Related]
10. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study.
Lai CH; Yang YH; Chen PC; King YC; Liu CY
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):191-198. PubMed ID: 29210149
[TBL] [Abstract][Full Text] [Related]
11. Is screening for interferon retinopathy in hepatitis C justified?
Cuthbertson FM; Davies M; McKibbin M
Br J Ophthalmol; 2004 Dec; 88(12):1518-20. PubMed ID: 15548803
[TBL] [Abstract][Full Text] [Related]
12. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.
Kim ET; Kim LH; Lee JI; Chin HS
Jpn J Ophthalmol; 2009 Nov; 53(6):598-602. PubMed ID: 20020238
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
Li Z; Zhang Y; An J; Feng Y; Deng H; Xiao S; Ji F
J Clin Virol; 2014 Jul; 60(3):190-5. PubMed ID: 24830933
[TBL] [Abstract][Full Text] [Related]
14. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C.
Adams S; Ostermeier M
Optometry; 2010 Nov; 81(11):580-6. PubMed ID: 20655283
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of peg-Interferon and Ribavirin combined antiviral treatment in a Romanian hepatitis C virus infected cohort.
Predescu O; Streba LA; Irimia E; Streba L; Mogoantă L
Rom J Morphol Embryol; 2012; 53(3):497-502. PubMed ID: 23010773
[TBL] [Abstract][Full Text] [Related]
16. [Retinopathy during interferon treatment in combination with ribavirin for chronic hepatitis C].
Nakamura T; Takahashi H; Koike N; Mitsutaka M; Soda M; Kimu M
Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):748-52. PubMed ID: 16363669
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmologic findings in hepatitis C patients treated with pegylated interferon α-2b and ribavirin.
Novelli FJ; Przysiezny A; Rosa EL; Garcia RF; Nóbrega MJ
Arq Bras Oftalmol; 2014; 77(3):178-81. PubMed ID: 25295906
[TBL] [Abstract][Full Text] [Related]
18. [Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
Iferkhass S; Elasri F; Chatioui S; Khoyaali A; Bargach T; Reda K; Oubaaz A
J Fr Ophtalmol; 2015 Jan; 38(1):34-40. PubMed ID: 25533994
[TBL] [Abstract][Full Text] [Related]
19. Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection.
Hermos JA; Quach L; Gagnon DR; Weber HC; Altincatal A; Cho K; Lawler EV; Grotzinger KM
Pharmacoepidemiol Drug Saf; 2014 May; 23(5):480-8. PubMed ID: 24677630
[TBL] [Abstract][Full Text] [Related]
20. Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Schulman JA; Liang C; Kooragayala LM; King J
Ophthalmology; 2003 Feb; 110(2):437-42. PubMed ID: 12578794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
